AFP and hepatocellular carcinoma: The combination of α-fetoprotein (AFP) levels with auto-antibody titers against 10 antigens increased the sensitivity for detecting stage 1 HCC by 40.00% and stage 2 by 55.00% over the tumor antigens auto-antibodies panel alone or AFP alone [51].